ArticleJournal of clinical biochemistry and nutrition2026
Association of serum vitamin D and serum vitamin C with the risk of melanoma among adults in the United States: a cross-sectional analysis of 2003-2006 and 2017-2018 NHANES data.
Article in Journal of clinical biochemistry and nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To analyze the relationship between serum Vitamin D (VD) and Vitamin C (VC) levels and melanoma risk in American adults using NHANES data. The exposure variables were serum VD and VC. The outcome variable was melanoma presence. Covariates included sex, age, race, BMI, poverty-income ratio, alcohol consumption, smoking, diabetes, hypertension, sunscreen use, and sunburn history. We use weighted logistic regression and restricted cubic spline (RCS) analyses to evaluate the relationship and receiver operating characteristic (ROC) curve to assess the prediction performance. Data from 12,743 (VD) and 12,615 (VC) participants were included. Higher serum VD levels (≥75 nmol/L) and the highest VC quartile levels (OR = 1.91, 95% CI: 1.24-2.97) were associated with an increased melanoma risk. The ROC analysis indicated that the combination of VC or VD with covariates exhibited excellent predictive efficacy (VD and VC model 3: AUC = 0.863). RCS analysis revealed a non-linear correlation between VD and melanoma, and a significant non-linear dose-response relationship between serum VC levels and melanoma. Stratified analysis indicated the adverse effect of higher VD on melanoma was more pronounced in men (OR = 3.55, 95% CI: 1.99-6.33;
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.